- Home
- SDOT vs MYNZ Comparison
SDOT vs MYNZ Comparison
Compare SDOT & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- MYNZ
- Stock Information
- Founded
- SDOT 2014
- MYNZ 2021
- Country
- SDOT United States
- MYNZ Germany
- Employees
- SDOT N/A
- MYNZ N/A
- Industry
- SDOT Restaurants
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- SDOT Consumer Discretionary
- MYNZ Health Care
- Exchange
- SDOT Nasdaq
- MYNZ Nasdaq
- Market Cap
- SDOT 7.6M
- MYNZ 7.9M
- IPO Year
- SDOT 2020
- MYNZ 2021
- Fundamental
- Price
- SDOT N/A
- MYNZ $1.60
- Analyst Decision
- SDOT
- MYNZ Buy
- Analyst Count
- SDOT 0
- MYNZ 2
- Target Price
- SDOT N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- SDOT 58.7K
- MYNZ 387.7K
- Earning Date
- SDOT 11-11-2025
- MYNZ 09-26-2025
- Dividend Yield
- SDOT N/A
- MYNZ N/A
- EPS Growth
- SDOT N/A
- MYNZ N/A
- EPS
- SDOT 6.14
- MYNZ N/A
- Revenue
- SDOT $667,695,000.00
- MYNZ $659,935.00
- Revenue This Year
- SDOT $12.76
- MYNZ $26.06
- Revenue Next Year
- SDOT $5.54
- MYNZ $4.97
- P/E Ratio
- SDOT $0.89
- MYNZ N/A
- Revenue Growth
- SDOT 7.00
- MYNZ N/A
- 52 Week Low
- SDOT $5.25
- MYNZ $1.28
- 52 Week High
- SDOT $57.00
- MYNZ $16.04
- Technical
- Relative Strength Index (RSI)
- SDOT 59.90
- MYNZ 35.56
- Support Level
- SDOT $5.62
- MYNZ $1.55
- Resistance Level
- SDOT $6.22
- MYNZ $1.73
- Average True Range (ATR)
- SDOT 0.49
- MYNZ 0.12
- MACD
- SDOT -0.21
- MYNZ -0.01
- Stochastic Oscillator
- SDOT 21.35
- MYNZ 5.56
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.